Marlborough medical products company Hologic was one of 55 corporations that paid no federal income taxes in 2020, according to the think tank Institute on Taxation and Economic Policy. Not only that, but Hologic got a federal credit of $62 million.
Marlborough early stage drugmaker Phio Pharmaceuticals, has ended the year in a strong position, with enough funding to continue its current programs for the next two years, the company announced last week.
Marlborough medical device company Boston Scientific has released newly obtained study data speaking to the effectiveness of its TheraSphere Y-90 Glass Microspheres cancer treatment.
Boston Scientific, a medical device manufacturer based in Marlborough, will pay out $188.6 million across 47 states and Washington, D.C., including $2.8 million for Massachusetts.
Marlborough medical device company Boston Scientific has received U.S. Food and Drug Administration approval for its TheraSphere Y-90 Glass Microspheres cancer treatment.
Hologic, a medical device company based in Marlborough, announced on Monday it is teaming up with Gallup, Inc., the Washington, D.C.-based analytics and advisory company, to develop the Hologic Women’s Health Index.
Marlborough medical device company Hologic has made yet another acquisition, this time picking up Belgium-based diagnostic company Diagenode for $159 million.